Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS In a double-blind...
Autores Principales: | , , , , , , , , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Massachusetts Medical Society
2011
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/26913 https://doi.org/10.1056/NEJMoa1009638 |